JP2010512747A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512747A5 JP2010512747A5 JP2009541384A JP2009541384A JP2010512747A5 JP 2010512747 A5 JP2010512747 A5 JP 2010512747A5 JP 2009541384 A JP2009541384 A JP 2009541384A JP 2009541384 A JP2009541384 A JP 2009541384A JP 2010512747 A5 JP2010512747 A5 JP 2010512747A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- isolated nucleic
- seq
- molecule according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86993706P | 2006-12-14 | 2006-12-14 | |
| PCT/US2007/025535 WO2008076324A2 (en) | 2006-12-14 | 2007-12-13 | Compositions and methods to treat muscular & cardiovascular disorders |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011178297A Division JP2012019789A (ja) | 2006-12-14 | 2011-08-17 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
| JP2012034691A Division JP2012131812A (ja) | 2006-12-14 | 2012-02-21 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010512747A JP2010512747A (ja) | 2010-04-30 |
| JP2010512747A5 true JP2010512747A5 (enExample) | 2011-02-03 |
Family
ID=39536897
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009541384A Withdrawn JP2010512747A (ja) | 2006-12-14 | 2007-12-13 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
| JP2011178297A Withdrawn JP2012019789A (ja) | 2006-12-14 | 2011-08-17 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
| JP2012034691A Withdrawn JP2012131812A (ja) | 2006-12-14 | 2012-02-21 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011178297A Withdrawn JP2012019789A (ja) | 2006-12-14 | 2011-08-17 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
| JP2012034691A Withdrawn JP2012131812A (ja) | 2006-12-14 | 2012-02-21 | 筋疾患および心臓血管障害を処置するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20100280094A1 (enExample) |
| EP (1) | EP2104733A2 (enExample) |
| JP (3) | JP2010512747A (enExample) |
| KR (1) | KR20090098818A (enExample) |
| CN (2) | CN102604951A (enExample) |
| AU (1) | AU2007334502B2 (enExample) |
| BR (1) | BRPI0719995A2 (enExample) |
| CA (1) | CA2672606A1 (enExample) |
| EA (2) | EA201101361A1 (enExample) |
| MX (1) | MX2009006310A (enExample) |
| WO (1) | WO2008076324A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2056882T3 (da) | 2006-08-01 | 2012-11-19 | Univ Texas | Identifikation af en mikro-rna, som aktiverer ekspression af en tung kæde med beta-myosin |
| CA2694928A1 (en) | 2007-07-31 | 2009-02-05 | Board Of Regents, The University Of Texas System | Micro-rnas that control myosin expression and myofiber identity |
| US8629119B2 (en) * | 2009-02-04 | 2014-01-14 | The Board Of Regents, The University Of Texas System | Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders |
| IE20090047A1 (en) * | 2009-02-26 | 2010-09-29 | Nat Univ Ireland | Protein targets in disease |
| US9034605B2 (en) | 2009-03-12 | 2015-05-19 | Brandeis University | Reagents and methods for PCR |
| EP2652151A2 (en) | 2010-12-15 | 2013-10-23 | Miragen Therapeutics | Microrna inhibitors comprising locked nucleotides |
| EP2763703B1 (en) | 2011-10-06 | 2018-02-14 | Miragen Therapeutics, Inc. | Control of whole body energy homeostasis by microrna regulation |
| EP2864482A4 (en) | 2012-06-21 | 2016-02-10 | Miragen Therapeutics Inc | OLIGONUCLEOTIDE INHIBITORS COMPRISING A BLOCKED NUCLEIC ACID PATTERN |
| EP2906697A4 (en) | 2012-10-15 | 2016-06-22 | Ionis Pharmaceuticals Inc | METHOD FOR MONITORING THE C9ORF72 EXPRESSION |
| US10443052B2 (en) * | 2012-10-15 | 2019-10-15 | Ionis Pharmaceuticals, Inc. | Compositions for modulating C9ORF72 expression |
| WO2014169126A1 (en) * | 2013-04-10 | 2014-10-16 | Reveragen Biopharma, Inc. | Methods and agents to increase therapeutic dystrophin expression in muscle |
| MY192689A (en) | 2013-10-11 | 2022-09-01 | Ionis Pharmaceuticals Inc | Compositions for modulating c9orf72 expression |
| WO2016022536A2 (en) * | 2014-08-04 | 2016-02-11 | MiRagen Therapeutics, Inc. | Inhibitors of myh7b and uses thereof |
| HK1249108A1 (zh) | 2015-01-20 | 2018-10-26 | 米拉根医疗股份有限公司 | Mir-92抑制剂及其用途 |
| WO2016168592A2 (en) | 2015-04-16 | 2016-10-20 | Ionis Pharmaceuticals, Inc. | Compositions for modulating c9orf72 expression |
| WO2017079291A1 (en) | 2015-11-02 | 2017-05-11 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating c90rf72 |
| CN106148519A (zh) * | 2016-07-05 | 2016-11-23 | 无锡市第二人民医院 | 一种microRNA‑499的快速检测方法 |
| US12054711B2 (en) | 2017-07-14 | 2024-08-06 | City Of Hope | Meta-stable oligonucleotides junctions for delivery of therapeutics |
| CN111630166B (zh) * | 2017-08-10 | 2024-04-19 | 希望之城 | 条件性-siRNA及其在治疗心肌肥大中的用途 |
| WO2019033083A1 (en) | 2017-08-10 | 2019-02-14 | City Of Hope | CONDITIONAL RNAIDS AND THEIR USES IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA |
| KR102281710B1 (ko) | 2021-02-19 | 2021-07-28 | 조기정 | 에어튜브를 이용한 선박 안전장치 |
| CN119246849B (zh) * | 2024-12-09 | 2025-03-14 | 上海基灵生物科技有限公司 | 一种检测犬心脏损伤的试剂盒及应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5489677A (en) * | 1990-07-27 | 1996-02-06 | Isis Pharmaceuticals, Inc. | Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms |
| US5602240A (en) * | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
| JPH06502300A (ja) * | 1990-08-03 | 1994-03-17 | サノフィ | 遺伝子発現の抑制のための化合物及び方法 |
| US5719262A (en) * | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
| US5700922A (en) * | 1991-12-24 | 1997-12-23 | Isis Pharmaceuticals, Inc. | PNA-DNA-PNA chimeric macromolecules |
| JP3516167B2 (ja) * | 1992-12-08 | 2004-04-05 | ローム株式会社 | タンタルコンデンサチップの製造方法 |
| US6271359B1 (en) * | 1999-04-14 | 2001-08-07 | Musc Foundation For Research Development | Tissue-specific and pathogen-specific toxic agents and ribozymes |
| CN100523215C (zh) * | 2000-12-01 | 2009-08-05 | 马普科技促进协会 | 介导rna干涉的小rna分子 |
| AU2004257373B2 (en) * | 2003-07-16 | 2011-03-24 | Arbutus Biopharma Corporation | Lipid encapsulated interfering RNA |
| WO2005021800A2 (en) * | 2003-08-22 | 2005-03-10 | Sirna Therapeutics, Inc. | Detection and quantitation of nucleic acid molecules in biological samples |
| CA2566519C (en) * | 2004-05-14 | 2020-04-21 | Rosetta Genomics Ltd. | Micrornas and uses thereof |
| US8592384B2 (en) * | 2005-04-04 | 2013-11-26 | The Board Of Regents Of The University Of Texas System | Micro-RNA's that regulate muscle cells |
| US20070092882A1 (en) * | 2005-10-21 | 2007-04-26 | Hui Wang | Analysis of microRNA |
| JP2009523013A (ja) * | 2006-01-10 | 2009-06-18 | コニンクリユケ ネーデルランドセ アカデミ ファン ウェテンスハッペン | 新規な核酸分子及びそのコレクション、並びにそれらの用途及び同定方法 |
| DK2056882T3 (da) * | 2006-08-01 | 2012-11-19 | Univ Texas | Identifikation af en mikro-rna, som aktiverer ekspression af en tung kæde med beta-myosin |
| CA2694928A1 (en) * | 2007-07-31 | 2009-02-05 | Board Of Regents, The University Of Texas System | Micro-rnas that control myosin expression and myofiber identity |
-
2007
- 2007-12-13 BR BRPI0719995-3A2A patent/BRPI0719995A2/pt not_active IP Right Cessation
- 2007-12-13 MX MX2009006310A patent/MX2009006310A/es not_active Application Discontinuation
- 2007-12-13 KR KR1020097012148A patent/KR20090098818A/ko not_active Withdrawn
- 2007-12-13 CN CN2012100499504A patent/CN102604951A/zh active Pending
- 2007-12-13 CA CA002672606A patent/CA2672606A1/en not_active Abandoned
- 2007-12-13 US US12/519,323 patent/US20100280094A1/en not_active Abandoned
- 2007-12-13 CN CNA2007800464358A patent/CN101563458A/zh active Pending
- 2007-12-13 JP JP2009541384A patent/JP2010512747A/ja not_active Withdrawn
- 2007-12-13 WO PCT/US2007/025535 patent/WO2008076324A2/en not_active Ceased
- 2007-12-13 EP EP07867751A patent/EP2104733A2/en not_active Withdrawn
- 2007-12-13 EA EA201101361A patent/EA201101361A1/ru unknown
- 2007-12-13 EA EA200900782A patent/EA200900782A1/ru unknown
- 2007-12-13 AU AU2007334502A patent/AU2007334502B2/en not_active Ceased
-
2011
- 2011-08-09 US US13/206,055 patent/US20120041052A1/en not_active Abandoned
- 2011-08-17 JP JP2011178297A patent/JP2012019789A/ja not_active Withdrawn
-
2012
- 2012-01-18 US US13/352,570 patent/US20120114744A1/en not_active Abandoned
- 2012-02-21 JP JP2012034691A patent/JP2012131812A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3222724T3 (en) | ADDITIONALLY UNKNOWN FORMS OF INTERFERRING RNA MOLECULES | |
| JP2015502365A5 (enExample) | ||
| JP2005517427A5 (enExample) | ||
| JP2013535212A5 (enExample) | ||
| EP1389637A1 (en) | Novel forms of interfering RNA molecules | |
| JP2014527401A5 (enExample) | ||
| JP2013510561A5 (enExample) | ||
| JP2005517438A5 (enExample) | ||
| BRPI0811170B8 (pt) | oligonucleotídeos de rna e complexos de rna substituídos por hidroximetila | |
| JP2005517432A5 (enExample) | ||
| JP2009524419A5 (enExample) | ||
| CA2457528A1 (en) | Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) | |
| JP2008283975A5 (enExample) | ||
| JP2012050438A5 (enExample) | ||
| JP2010530239A5 (enExample) | ||
| JP2005517452A5 (enExample) | ||
| JP2012504389A (ja) | 修飾を有するｄｓＲＮＡによる遺伝子発現の特異的な阻害のための組成物および方法 | |
| JP2009532392A5 (enExample) | ||
| JP2005517436A5 (enExample) | ||
| CN104388427A (zh) | miRNA-200b在制备β-catenin抑制剂的新用途 | |
| JP2010532163A5 (enExample) | ||
| WO2010120969A1 (en) | Targeting of the mir-30 family and let-7 family as a treatment for heart disease | |
| JP2024531728A5 (enExample) | ||
| JP2024500036A5 (enExample) | ||
| WO2010006973A3 (en) | Compositions and methods for inhibiting expression of tgf-beta receptor genes |